The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trialWilleke F. Westendorp, Paul J. Nederkoorn, Nyika D. Kruyt et al.|The Lancet|2015Cited by 328
Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trialFloris H.B.M. Schreuder, Catharina J.M. Klijn, Koen M. van Nieuwenhuizen et al.|The Lancet Neurology|2021Cited by 101